Dimerix Ltd
DXB•Health Care•Biotechnology•Last updated: Dec 25
About
Dimerix Ltd is a clinical-stage biopharmaceutical company focused on developing innovative therapies for unmet medical needs. The company specializes in the development of treatments for inflammatory diseases and kidney disorders, with its lead product candidate targeting focal segmental glomerulosclerosis (FSGS) and diabetic kidney disease. Dimerix utilizes its proprietary Receptor-HIT platform to identify and develop new drug candidates.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- DXB
Related Shares
Investor Resources
Should you buy Dimerix Ltd right now?
While DXB looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now